Riskpilot← Back to searchSign inGet full accessOrtopedi Syd AB
ABActiveOrg 5569842882Norra Fågelsträcket 5 AMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
SEK 5,3M
0% vs 2024
EBITDA margin
19.6%
+46% vs 2024
Equity ratio
77.1%
Financial strength
Net profit 2025
SEK 816K
+46% vs 2024
| Revenue | SEK 5,3M | +0% |
| EBITDA | SEK 1M | +46% |
| Net profit | SEK 816K | +46% |
| Total assets | SEK 1,9M | +0% |
| Equity | SEK 1,5M | +9% |
| Employees | 1 | — |
Legal name
Ortopedi Syd AB
Org number
5569842882
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 september 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Ortopedisk utredning, behandling, rehabilitering. Ortopedisk konsultverksamhet.
Address
Norra Fågelsträcket 5 A
Email
johan_e.nilsson@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 022 | 5 133 | 5 249 | 5 298 | 5 303 |
| Staff expenses | — | — | — | −1 667 | −1 307 |
| EBITDA | 691 | 818 | 987 | 714 | 1 040 |
| Depreciation & amort. | −0 | −0 | −6 | −6 | −6 |
| EBIT | 691 | 818 | 981 | 709 | 1 034 |
| Net financials | −5 | −3 | −59 | −1 | 0 |
| Profit before tax | 685 | 815 | 950 | 707 | 1 035 |
| Tax | −148 | −169 | −206 | −149 | −218 |
| Net profit | 537 | 646 | 744 | 558 | 816 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 078 | 2 180 | 1 951 | 1 926 | 1 925 |
| Equity | 1 220 | 1 286 | 1 410 | 1 358 | 1 484 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 858 | 894 | 541 | 568 | 440 |
| Total debt | 858 | 894 | 541 | 568 | 440 |
EBITDA margin
19.6%
This company
15.8%
Market median
+24% vs market
20212025
Equity ratio
77.1%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
55.0%
This company
18.4%
Market median
+199% vs market
20212025
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
20212025
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 |
AM | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ortopedi Syd AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Kerstin Birgitta Berntsdotter | Deputy Chief Executive Officer | 0 companies |
| Anette Madelein Samzelius | Audit | 0 companies |
| Johan Erik Ragnar Nilsson | Chairman | 0 companies |
| Per Olof Bosemark | Deputy Board Member | 0 companies |